# American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on June 24, 2026
Canonical URL: https://biopharmsignal.com/news/AMS/american-shared-hospital-services-announces-annual-shareholder-meeting-to-be-hel-653bf181
Ticker: AMS
Company: American Shared Hospital Services
Source: American Shared Hospital Services
Published: 2026-05-22 11:00 EST
## Summary

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on June 24, 2026...

## Article Body
American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, today announced that its Annual Meeting of Shareholders will be held on June 24, 2026, at 9:00 a.m. CT.

The Annual Meeting will be a virtual meeting via a live audio webcast that is available at: www.virtualshareholdermeeting.com/AMS2026 . There will be no physical Meeting location and the Meeting will only be conducted via the live audio webcast. To participate in the Meeting you must have your 16-digit control number that is shown on your proxy card.

The Board of Directors fixed the close of business on April 27, 2026, as the record date for determination of shareholders entitled to notice of and to vote at the Annual Meeting. Information on items of business to be addressed at the meeting, can be found in the Company’s 2026 proxy statement at: https://www.ashs.com/investors/sec-filings/ .

About American Shared Hospital Services (NYSE American: AMS)

American Shared Hospital Services (AMS) is a leading provider of turnkey solutions to cancer treatment centers, health systems, and cancer networks in North and South America. The Company works closely with its partners to develop and grow their cancer service lines and provide integrated cancer care to patients in a convenient local setting close to home. For centers under health system partnerships, the Company and its health system partners share in the capital investment cost and profitability of the operations based on their respective ownership interests. For more information, please visit: www.ashs.com

Contacts American Shared Hospital Services Ray Stachowiak, Executive Chairman rstachowiak@ashs.com

Investor Relations Kirin Smith, President PCG Advisory, Inc. ksmith@pcgadvisory.com
## Recent Company News
- 2026-05-22 11:00 EST — [American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on June 24, 2026](https://biopharmsignal.com/news/AMS/american-shared-hospital-services-announces-annual-shareholder-meeting-to-be-hel-653bf181) — Source: American Shared Hospital Services
- 2026-05-14 11:00 EST — [American Shared Hospital Services Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/AMS/american-shared-hospital-services-reports-first-quarter-2026-financial-results-ac741558) — Source: American Shared Hospital Services
- 2026-05-12 11:00 EST — [American Shared Hospital Services Announces First Quarter 2026 Financial Results Conference Call](https://biopharmsignal.com/news/AMS/american-shared-hospital-services-announces-first-quarter-2026-financial-results-bc86f115) — Source: American Shared Hospital Services
- 2026-03-31 11:00 EST — [American Shared Hospital Services Reports Fourth Quarter and Full Year 2025 Financial Results](https://biopharmsignal.com/news/AMS/american-shared-hospital-services-reports-fourth-quarter-and-full-year-2025-fina-403f36a2) — Source: American Shared Hospital Services
- 2026-03-24 11:00 EST — [American Shared Hospital Services Announces Fourth Quarter and Full Year Financial Results Conference Call](https://biopharmsignal.com/news/AMS/american-shared-hospital-services-announces-fourth-quarter-and-full-year-financi-50561737) — Source: American Shared Hospital Services
## Related News
- 2026-07-29 20:05 EST — SERA — [SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026](https://biopharmsignal.com/news/SERA/sera-prognostics-announces-conference-call-and-webcast-of-second-quarter-fiscal--2a2c0c5a)
- 2026-07-29 20:05 EST — VKTX — [Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/VKTX/viking-therapeutics-reports-second-quarter-2026-financial-results-and-provides-c-2f09b8ce)
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)